High levels of IDO, TPH1, HTR2B, AhR, and Kyn predict a poor prognosis in pancreatic cancer, whereas MAOA expression is negatively correlated with TNM stage and tumor size in pancreatic cancer, predicting a favorable prognosis [77, 78, 80, 81]. This evidence concerns the gene AHR and pancreatic neoplasm.